Leal-Gonzalez E.
39
Coauthors
4
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Medicina interna | 2 |
| Farmacología | 1 |
| Enfermedad cardiovascular | 1 |
| Nutrición | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Fisiología humana | 3 |
| Farmacología y terapéutica | 3 |
| Enfermedades | 3 |
| Salud y seguridad personal | 2 |
| Medicina y salud | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 4 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Valmore Bermúdez | 4 |
| Mengual-Moreno E. | 4 |
| Cano-Ponce C. | 4 |
| Bermúdez-Arias F. | 2 |
| Israili Z.H. | 2 |
| Valasco M. | 2 |
| Arráiz N. | 2 |
| Lemus-Antepaz M. | 2 |
| Souki-Rincón A. | 2 |
| Cabrera De Bravo M.C. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Malondialdehide and reduced glutathione increase in patients with chronic stable ischaemic cardiopathy
ArticleAbstract: BACKGROUND AND OBJECTIVE: Cardiovascular diseases are associated with the ischemia/reperfusion phenoPalabras claves:Chronic ischemic heart disease, Coronary disease, Oxidation/antioxidationAutores:Bermúdez-Arias F., Cabrera De Bravo M.C., Cano-Ponce C., Leal-Gonzalez E., Mengual-Moreno E., Valmore BermúdezFuentes:scopusLipoprotein (a) in an urban population of Venezuela: Evidence that estrogenic deprivation increase in lipoprotein (A) levels is transitory
ArticleAbstract: Background: Lipoprotein (a) [Lp (a)] is an independent risk factor for coronary artery disease and nPalabras claves:Apo (a), Hormonal replacement therapy, Lipoprotein (a), risk factor, Tissue plasminogen activatorAutores:Amell De Díaz A., Cabrera De Bravo M.C., Cano-Ponce C., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Sorell Gómez L., Valmore BermúdezFuentes:scopusOat-derived β-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia
Conference ObjectAbstract: OBJECTIVE: To investigate the effect of bread formulated with 6 g of β-glucan (oat soluble fiber) onPalabras claves:HDL cholesterol, LDL cholesterol, LDL cholesterol/HDL cholesterol ratio, Non-HDL cholesterol, Oat soluble fiber, Total cholesterol/HDL cholesterol ratio, β-glucanAutores:Arias N., Arráiz N., Cano-Ponce C., Hernández-Hernandez R., Inglett G.E., Israili Z.H., Leal-Gonzalez E., Mengual-Moreno E., Reyna-Villasmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusCiprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with frederickson type IV dyslipidemia phenotype
Conference ObjectAbstract: OBJECTIVE: The combination of hypertriglyceridemia and low high density lipoprotein (HDL) cholesteroPalabras claves:Ciprofibrate, Frederickson's type IV dyslipidemia, High density lipoprotein cholesterol, Hyperlipidemia, Low density lipoprotein cholesterol, Non-high density lipoprotein cholesterol, TriglyceridesAutores:Arráiz N., Bermúdez-Arias F., Cano-Peñaloza R., Cano-Ponce C., Contreras F., de Bravo M.C., De Diaz A.A., De Pirela N.L., Israili Z.H., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Puche-Medina G., Reyna-Villazmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopus